Free Trial

Nissan Chemical Corporation Unsponsored ADR (OTCMKTS:NNCHY) Short Interest Down 36.4% in August

Nissan Chemical logo with Basic Materials background

Key Points

  • Nissan Chemical Corporation experienced a significant decline in short interest, dropping by 36.4% in August, with total short interest at 700 shares as of August 31st.
  • The company's stock opened at $34.04 and has a market capitalization of $4.66 billion, with a PE ratio of 15.26.
  • In its latest earnings report, Nissan Chemical reported earnings of $0.71 per share and revenue of $483.65 million for the quarter ending August 8th.
  • MarketBeat previews the top five stocks to own by October 1st.

Nissan Chemical Corporation Unsponsored ADR (OTCMKTS:NNCHY - Get Free Report) saw a significant drop in short interest in August. As of August 31st, there was short interest totaling 700 shares, a drop of 36.4% from the August 15th total of 1,100 shares. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 500 shares, the days-to-cover ratio is presently 1.4 days.

Nissan Chemical Stock Performance

Shares of OTCMKTS:NNCHY opened at $34.04 on Monday. Nissan Chemical has a twelve month low of $24.00 and a twelve month high of $39.57. The firm has a market cap of $4.66 billion, a PE ratio of 15.26 and a beta of -0.08. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.63 and a current ratio of 2.58. The business has a fifty day moving average of $34.90 and a 200-day moving average of $31.79.

Nissan Chemical (OTCMKTS:NNCHY - Get Free Report) last announced its earnings results on Friday, August 8th. The company reported $0.71 earnings per share for the quarter. Nissan Chemical had a return on equity of 18.88% and a net margin of 17.30%.The company had revenue of $483.65 million during the quarter.

Nissan Chemical Company Profile

(Get Free Report)

Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete and civil engineering-related products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; TEPIC-FL, a liquid epoxy material; FOLDI-E101, an epoxy reactive diluent; Ecopromote, a nucleating agents for PLA; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; OPTBEADS, a melamine-formaldehyde resin and silica; and FINEOXOCOL, a saturated fatty alcohol and acid.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nissan Chemical Right Now?

Before you consider Nissan Chemical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nissan Chemical wasn't on the list.

While Nissan Chemical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.